US Patent Awarded to Singulex for Expanded Use of Biomarkers Troponin I and T to Detect Cardiac Health Status With Single-Molecule Methods
November 12, 2015 09:00 ET
|
Singulex, Inc.
ALAMEDA, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Singulex, Inc., the developer of Single Molecule Counting technology for use in both medical practice diagnostics and scientific research, has...
Singulex Receives European Patent Expanding Use of Biomarkers Troponin I and T to Detect Cardiac Health Status With High-Sensitivity Methods
November 05, 2015 09:00 ET
|
Singulex, Inc.
ALAMEDA, Calif., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Singulex, Inc., the developer of Single Molecule Counting technology for use in both medical practice diagnostics and scientific research, has...
Singulex Demonstrates Ultrasensitive "Sgx Clarity(TM) System" at AACC 2015
July 14, 2015 11:00 ET
|
Singulex, Inc.
– Single Molecule Counting technology at the heart of development of a new in vitro diagnostics system; Company plans to commercialize in 2016 –
– Multiple presentations...
Singulex Announces EMD Millipore to Acquire Exclusive Rights to Singulex's Ultra-Sensitive Single Molecule Counting (SMC(TM)) Technology
May 21, 2015 09:00 ET
|
Singulex, Inc.
- EMD Millipore to acquire exclusive worldwide rights to Singulex's SMCTM technology – instruments, assays and services – for research applications -
- Combination of Singulex's...
Singulex Announces Partnership With The Dutch Technology Foundation (STW) to Accelerate the Development of Clinical Biomarkers
April 30, 2015 10:00 ET
|
Singulex, Inc.
ALAMEDA, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Singulex, Inc., the developer and leading provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery, today...
Singulex Key Patent Granted in Japan for Detecting or Monitoring Cardiovascular Disease Using Proprietary Biomarkers
April 28, 2015 10:00 ET
|
Singulex, Inc.
ALAMEDA, Calif., April 28, 2015 (GLOBE NEWSWIRE) -- Singulex, Inc., the developer and leading provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery, today...
Singulex Announces Collaboration With CHDI Foundation to Develop Biomarker Assays for Huntington's Disease
April 09, 2015 10:00 ET
|
Singulex, Inc.
– Earlier research using Singulex's Huntington's disease research immunoassay outlined in Journal of Clinical Investigation –
– Assay measures build-up of a harmful mutant...